The pharmaceutical firm will pay $425m up-front for University of Michigan and Ohio State University-founded OncoImmune after the latter pivoted its research pipeline to target severe cases of covid-19.

The Comcast and Anthem-backed telemedicine app developer closed its second round of the year, at a reported $700m valuation.

The Alphabet investment vehicle has helped the online therapist network close a series A round that increased its total funding to $32m.

Northwestern Mutual Future Ventures has reserved $20m for strategic investments in startups with black founders and formed a dedicated accelerator.

The WuXi AppTec, Celgene, Taikang and Tigermed-backed cancer drug developer went public in Hong Kong at the top of its range.

Strategic partner PPD returned for a round that helped the clinical trial software provider take its total funding past the $130m mark.

Pharmaron Investments, Amgen Ventures and MRL Ventures Fund helped the bone marrow cancer drug developer double its total funding to about $160m.

LBO France’s Digital Health 2, which has a targeted close of about $240m, has secured Orange and its Enovacom subsidiary as a limited partner.

The digital healthcare platform developer secured $32.4m from investors including Apotek Hjärtat, which acquired a 42% stake two years ago.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.